|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang C, Chen Y, Zhu Y and Xu Y:
Systematic review and meta-analysis of the accuracy of 18F-FDG
PET/CT for detection of regional lymph node metastasis in
esophageal squamous cell carcinoma. J Thorac Dis. 10:6066–6076.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim M: Evaluation of a web-based App
demonstrating an exclusionary algorithmic approach to TNM cancer
staging. JMIR Cancer. 1:e32015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang X, Wang Y, Zhao L, Sang S and Zhang
L: Prognostic value of platelet-to-lymphocyte ratio in oncologic
outcomes of esophageal cancer: A systematic review and
meta-analysis. Int J Biol Markers. Apr 1–2018.(Epub ahead of
print). View Article : Google Scholar
|
|
5
|
Quan J, Pan X, Zhao L, Li Z, Dai K, Yan F,
Liu S, Ma H and Lai Y: LncRNA as a diagnostic and prognostic
biomarker in bladder cancer: A systematic review and meta-analysis.
Onco Targets Ther. 11:6415–6424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tian T, Wang M, Lin S, Guo Y, Dai Z, Liu
K, Yang P, Dai C, Zhu Y, Zheng Y, et al: The impact of lncRNA
dysregulation on clinicopathology and survival of breast cancer: A
systematic review and meta-analysis. Mol Ther Nucleic Acids.
12:359–369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu W, Zhang Y, Chen M, Shi L, Xu L and
Zou X: A genome-wide analysis of long noncoding RNA profile
identifies differentially expressed lncRNAs associated with
Esophageal cancer. Cancer Med. 7:4181–4189. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khadirnaikar S, Narayanan SP and Shukla
SK: Decoding the LncRNA transcriptome of esophageal cancer:
Identification of clinically relevant LncRNAs. Biomark Med.
12:1083–1093. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ji S, Yang W, Liu J, Zhao J, Chen L, Ni Q,
Long J and Yu X: High throughput gene sequencing reveals altered
landscape in DNA damage responses and chromatin remodeling in
sporadic pancreatic neuroendocrine tumors. Pancreatology.
18:318–327. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krishnamurthy A, Ferl RJ and Paul AL:
Comparing RNA-Seq and microarray gene expression data in two zones
of the Arabidopsis root apex relevant to spaceflight. Appl Plant
Sci. 6:e011972018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu J, Zhou L, Song Z, Xiong M, Zhang Y,
Yang Y, Chen K and Chen Z: The identification of new biomarkers for
bladder cancer: A study based on TCGA and GEO datasets. J Cell
Physiol. Feb 18–2019.(Epub ahead of print). View Article : Google Scholar
|
|
12
|
Su H, Hu N, Yang HH, Wang C, Takikita M,
Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, et al: Global
gene expression profiling and validation in esophageal squamous
cell carcinoma and its association with clinical phenotypes. Clin
Cancer Res. 17:2955–2966. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Q, Ma C and Kemmner W: Wdr66 is a
novel marker for risk stratification and involved in
epithelial-mesenchymal transition of esophageal squamous cell
carcinoma. BMC Cancer. 13:1372013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen J, Yang H, Liu MZ, Luo KJ, Liu H, Hu
Y, Zhang X, Lai RC, Lin T, Wang HY and Fu JH: Gene expression
analysis of pretreatment biopsies predicts the pathological
response of esophageal squamous cell carcinomas to
neo-chemoradiotherapy. Ann Oncol. 25:1769–1774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo Y, Chen Z, Zhang L, Zhou F, Shi S,
Feng X, Li B, Meng X, Ma X, Luo M, et al: Distinctive microRNA
profiles relating to patient survival in esophageal squamous cell
carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jang HJ, Lee HS, Burt BM, Lee GK, Yoon KA,
Park YY, Sohn BH, Kim SB, Kim MS, Lee JM, et al: Integrated genomic
analysis of recurrence-associated small non-coding RNAs in
oesophageal cancer. Gut. 66:215–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao B, Yang W, Jin Y, Zhang M, He T, Zhan
Q, Herman JG, Zhong G and Guo M: Silencing NKD2 by promoter region
hypermethylation promotes esophageal cancer progression by
activating Wnt signaling. J Thorac Oncol. 11:1912–1926. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X, Zhu Y, Zhu L, Chen X, Xu Y, Zhao
Y, Shao Y, Li F, Jiang Y, Lu J, et al: Eupatilin inhibits the
proliferation of human esophageal cancer TE1 cells by targeting the
Akt-GSK3β and MAPK/ERK signaling cascades. Oncol Rep. 39:2942–2950.
2018.PubMed/NCBI
|
|
20
|
Jiang JH, Pi J, Jin H and Cai JY:
Oridonin-induced mitochondria-dependent apoptosis in esophageal
cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways. J
Cell Biochem. 120:3736–3746. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He J, Zhao J, Zhu W, Qi D, Wang L, Sun J,
Wang B, Ma X, Dai Q and Yu X: MicroRNA biogenesis pathway genes
polymorphisms and cancer risk: A systematic review and
meta-analysis. PeerJ. 4:e27062016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu M, Zhu S, Xiong S, Xue X and Zhou X:
MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
Oncol Rep. 41:1439–1454. 2019.PubMed/NCBI
|
|
23
|
Xiao YF, Yong X, Tang B, Qin Y, Zhang JW,
Zhang D, Xie R and Yang SM: Notch and Wnt signaling pathway in
cancer: Crucial role and potential therapeutic targets (Review).
Int J Oncol. 48:437–449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toren P and Zoubeidi A: Targeting the
PI3K/Akt pathway in prostate cancer: Challenges and opportunities
(Review). Int J Oncol. 45:1793–1801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayashi Y, Nishida T, Tsujii M, Tsutsui S,
Yamamoto K, Isohashi F, Yamasaki M, Miyata H, Kato M, Yamada T, et
al: Lymph node enlargement after definitive chemoradiotherapy for
clinical stage I esophageal squamous cell carcinoma. BMC Cancer.
14:7062014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng YF, Chen HS, Wu SC, Chen HC, Hung
WH, Lin CH and Wang BY: Esophageal squamous cell carcinoma and
prognosis in Taiwan. Cancer Med. 7:4193–4201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mine S, Watanabe M, Kumagai K, Okamura A,
Yuda M, Hayami M, Yamashita K, Imamura Y and Ishizuka N: Comparison
of mediastinal lymph node metastases from adenocarcinoma of the
esophagogastric junction versus lower esophageal squamous cell
carcinoma with involvement of the esophagogastric junction. Dis
Esophagus. Feb 22–2019.(Epub ahead of print). View Article : Google Scholar :
|
|
28
|
Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao
HH, Zhu Y, He JZ, Li CQ, Li EM and Xu LY: A three-lncRNA signature
predicts overall survival and disease-free survival in patients
with esophageal squamous cell carcinoma. BMC Cancer. 18:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Sun D, Wu K, Liu J, Zhao M, Li X,
Xu Y and Li B: Genome-wide analysis of long non-coding RNAs in
esophageal squamous cell carcinoma reveals their potential role in
invasion and metastasis. Thorac Cancer. 10:78–89. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alaei S, Sadeghi B, Najafi A and
Masoudi-Nejad A: LncRNA and mRNA integration network reconstruction
reveals novel key regulators in esophageal squamous-cell carcinoma.
Genomics. 111:76–89. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Campbell JD, Liu G, Luo L, Xiao J, Gerrein
J, Juan-Guardela B, Tedrow J, Alekseyev YO, Yang IV, Correll M, et
al: Assessment of microRNA differential expression and detection in
multiplexed small RNA sequencing data. RNA. 21:164–171. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Collins JE, Wali N, Sealy IM, Morris JA,
White RJ, Leonard SR, Jackson DK, Jones MC, Smerdon NC, Zamora J,
et al: High-throughput and quantitative genome-wide messenger RNA
sequencing for molecular phenotyping. BMC Genomics. 16:5782015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ozsolak F: Attomole-level genomics with
single-molecule direct DNA, cDNA and RNA sequencing technologies.
Curr Issues Mol Biol. 18:43–48. 2016.PubMed/NCBI
|
|
34
|
Lacaze É, Gendron AD, Miller JL, Colson
TL, Sherry JP, Giraudo M, Marcogliese DJ and Houde M: Cumulative
effects of municipal effluent and parasite infection in yellow
perch: A field study using high-throughput RNA-sequencing. Sci
Total Environ. 665:797–809. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ge L, Liu S, Xie L, Sang L, Ma C and Li H:
Differential mRNA expression profiling of oral squamous cell
carcinoma by high-throughput RNA sequencing. J Biomed Res.
29:2015.(Epub ahead of print). PubMed/NCBI
|
|
36
|
Gao M, Zhong A, Patel N, Alur C and Vyas
D: High throughput RNA sequencing utility for diagnosis and
prognosis in colon diseases. World J Gastroenterol. 23:2819–2825.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma T, Liang F, Oesterreich S and Tseng GC:
A joint bayesian model for integrating microarray and RNA
sequencing transcriptomic data. J Comput Biol. 24:647–662. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yan Y, Li S, Wang S, Rubegni P, Tognetti
L, Zhang J and Yan L: Long noncoding RNA HAND2-AS1 inhibits cancer
cell proliferation, migration, and invasion in esophagus squamous
cell carcinoma by regulating microRNA-21. J Cell Biochem.
120:9564–9571. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dong Z, Zhang A, Liu S, Lu F, Guo Y, Zhang
G, Xu F, Shi Y, Shen S, Liang J and Guo W: Aberrant
methylation-mediated silencing of lncRNA MEG3 functions as a ceRNA
in esophageal cancer. Mol Cancer Res. 15:800–810. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang ZL, Chen RP, Zhou XT, Zhan HL, Hu
MM, Liu B, Wu GD and Wu LF: Long non-coding RNA MEG3 induces cell
apoptosis in esophageal cancer through endoplasmic reticulum
stress. Oncol Rep. 37:3093–3099. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang S, Ning Q, Zhang G, Sun H, Wang Z and
Li Y: Construction of differential mRNA-lncRNA crosstalk networks
based on ceRNA hypothesis uncover key roles of lncRNAs implicated
in esophageal squamous cell carcinoma. Oncotarget. 7:85728–85740.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zang W, Wang T, Wang Y, Chen X, Du Y, Sun
Q, Li M, Dong Z and Zhao G: Knockdown of long non-coding RNA
TP73-AS1 inhibits cell proliferation and induces apoptosis in
esophageal squamous cell carcinoma. Oncotarget. 7:19960–19974.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou XL, Wang WW, Zhu WG, Yu CH, Tao GZ,
Wu QQ, Song YQ, Pan P and Tong YS: High expression of long
non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor
prognosis in patients with esophageal squamous cell carcinoma
treated with definitive chemoradiotherapy. Mol Carcinog.
55:2095–2105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shi H, Liu Z, Pei D, Jiang Y, Zhu H and
Chen B: Development and validation of nomogram based on lncRNA
ZFAS1 for predicting survival in lymph node-negative esophageal
squamous cell carcinoma patients. Oncotarget. 8:59048–59057.
2017.PubMed/NCBI
|
|
45
|
Wang P, Guo Q, Gao Y, Zhi H, Zhang Y, Liu
Y, Zhang J, Yue M, Guo M, Ning S, et al: Improved method for
prioritization of disease associated lncRNAs based on ceRNA theory
and functional genomics data. Oncotarget. 8:4642–4655.
2017.PubMed/NCBI
|
|
46
|
Hu Q, Tai S and Wang J: Oncogenicity of
lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
Pathol Res Pract. 215:843–848. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Stelzer Y, Sagi I, Yanuka O, Eiges R and
Benvenisty N: The noncoding RNA IPW regulates the imprinted
DLK1-DIO3 locus in an induced pluripotent stem cell model of
Prader-Willi syndrome. Nat Genet. 46:551–557. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zang Y, Zhou X, Wang Q, Li X and Huang H:
LncRNA FIRRE/NF-kB feedback loop contributes to OGD/R injury of
cerebral microglial cells. Biochem Biophys Res Commun. 501:131–138.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Su C, Shi K, Cheng X, Han Y, Li Y, Yu D
and Liu Z: Long noncoding RNA LINC00472 inhibits proliferation and
promotes apoptosis of lung adenocarcinoma cells via regulating
miR-24-3p/DEDD. Technol Cancer Res Treat. 17:15330338187904902018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lu T, Chen D, Wang Y, Sun X, Li S, Miao S,
Wo Y, Dong Y, Leng X, Du W and Jiao W: Identification of DNA
methylation-driven genes in esophageal squamous cell carcinoma: A
study based on the cancer genome atlas. Cancer Cell Int. 19:522019.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang W, Qu Y, Tan B, Jia Y, Wang N, Hu P
and Wang J: Prognostic significance of preoperative IKBKE
expression in esophageal squamous cell carcinoma. Onco Targets
Ther. 11:1305–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Maehara O, Suda G, Natsuizaka M, Ohnishi
S, Komatsu Y, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, et al:
Fibroblast growth factor-2-mediated FGFR/Erk signaling supports
maintenance of cancer stem-like cells in esophageal squamous cell
carcinoma. Carcinogenesis. 38:1073–1083. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Unger JM, Vaidya R, Hershman DL, Minasian
LM and Fleury ME: Systematic review and meta-analysis of the
magnitude of structural, clinical, and physician and patient
barriers to cancer clinical trial participation. J Natl Cancer
Inst. 111:245–255. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li PD, Hu JL, Ma C, Ma H, Yao J, Chen LL,
Chen J, Cheng TT, Yang KY, Wu G, et al: Upregulation of the long
non-coding RNA PVT1 promotes esophageal squamous cell carcinoma
progression by acting as a molecular sponge of miR-203 and LASP1.
Oncotarget. 8:34164–34176. 2017.PubMed/NCBI
|
|
55
|
Bao J, Zhou C, Zhang J, Mo J, Ye Q, He J
and Diao J: Upregulation of the long noncoding RNA FOXD2-AS1
predicts poor prognosis in esophageal squamous cell carcinoma.
Cancer Biomark. 21:527–533. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kang M, Ren M, Li Y, Fu Y, Deng M and Li
C: Exosome-mediated transfer of lncRNA PART1 induces gefitinib
resistance in esophageal squamous cell carcinoma via functioning as
a competing endogenous RNA. J Exp Clin Cancer Res. 37:1712018.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen LP, Wang H, Zhang Y, Chen QX, Lin TS,
Liu ZQ and Zhou YY: Robust analysis of novel mRNA-lncRNA cross talk
based on ceRNA hypothesis uncovers carcinogenic mechanism and
promotes diagnostic accuracy in esophageal cancer. Cancer Manag
Res. 11:347–358. 2018. View Article : Google Scholar : PubMed/NCBI
|
